(Q24194988)

inferred from title

congestive heart failure

1 reference

3

0 references

Sheila A Fisher

1

object named as

Sheila A Fisher

0 references

Enca Martin-Rendon

6

object named as

Enca Martin-Rendon

0 references

author name string

Susan J Brunskill

2

0 references

Anthony Mathur

4

0 references

David P Taggart

Cochrane Database of Systematic Reviews

5

0 references

publication date

29 April 2014

0 references

published in

0 references

cites work

Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

G-CSF Stimulation and Coronary Reinfusion of Mobilized Circulating Mononuclear Proangiogenic Cells in Patients with Chronic Ischemic Heart Disease: Five-Year Results of the TOPCARE-G-CSF Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Isolated coronary artery bypass graft combined with bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: a single-center, randomized, double-blind, placebo-control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Intramyocardial, autologous CD34+ cell therapy for refractory angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: an analysis from ACT34-CMI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Improvement of myocardial perfusion reserve detected by cardiovascular magnetic resonance after direct endomyocardial implantation of autologous bone marrow cells in patients with severe coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: an intra-patient comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Intracoronary autologous CD34+ stem cell therapy for intractable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Feasibility of trans-endocardial cell transplantation in chronic ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Role of imaging in cardiac stem cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Randomized controlled trial on the cardioprotective effect of bone marrow cells in patients undergoing coronary bypass graft surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Cardiac resynchronization therapy and bone marrow cell transplantation in patients with ischemic heart failure and electromechanical dyssynchrony: a randomized pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

One-year follow-up of transcoronary sinus administration of autologous bone marrow in patients with chronic refractory angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Multicenter randomized trial of cell therapy in cardiopathies - MiHeart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Validating intramyocardial bone marrow stem cell therapy in combination with coronary artery bypass grafting, the PERFECT Phase III randomized multicenter trial: study protocol for a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Transcoronary transplantation of progenitor cells after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Adult cardiac stem cells are multipotent and support myocardial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Stem cell treatment for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Stem cell treatment for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Stem cells and repair of the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Bone marrow cells regenerate infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Mobilized bone marrow cells repair the infarcted heart, improving function and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigato

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Iron particles for noninvasive monitoring of bone marrow stromal cell engraftment into, and isolation of viable engrafted donor cells from, the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve-month follow-up results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

7 January 2021

Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

7 January 2021

Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

7 January 2021

A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

7 January 2021

Cardiac magnetic resonance imaging at 3 and 15 months after application of circulating progenitor cells in recanalised chronic total occlusions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

7 January 2021

Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

7 January 2021

Autologous bone-marrow stem-cell transplantation for myocardial regeneration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

7 January 2021

Cell therapy in myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

7 January 2021

Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

7 January 2021

Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

7 January 2021

Five-year results of intracoronary infusion of the mobilized peripheral blood stem cells by granulocyte colony-stimulating factor in patients with myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

7 January 2021

Residual viability is a predictor of the perfusion enhancement obtained with the cell therapy of chronic myocardial infarction: a pilot multimodal imaging study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

7 January 2021

Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

7 January 2021

Intramyocardial bone marrow-derived mononuclear cell injection for chronic myocardial ischemia: the effect on diastolic function

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

7 January 2021

Bypass grafts and cell transplant in heart failure with low ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

7 January 2021

Repeated intracoronary infusion of peripheral blood stem cells with G-CSF in patients with refractory ischemic heart failure--a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007888.PUB2

7 January 2021

10.1002/14651858.CD007888.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

258392

258392

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference